A Study of Revumenib and Mezigdomide in People With Leukemia

Clinical trial NCT07356154 · RECRUITING

Trial details

NCT number: NCT07356154
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia Acute Leukemia Relapse Leukemia Refractory Leukemia Refractory Acute Leukemia Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Mixed Phenotype Acute Leukemia

Start date: 2026-01-16
Primary completion: 2029-01-16
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.